Free Trial

Merck & Co., Inc. (MRK) Short Interest Ratio & Short Volume

Merck & Co., Inc. logo
$97.43 +0.89 (+0.92%)
(As of 11/20/2024 ET)

Merck & Co., Inc. Short Interest Data

Merck & Co., Inc. (MRK) has a short interest of 26.23 million shares. This marks a 0.73% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 10.55 million shares to cover all short positions.

Current Short Interest
26,230,000 shares
Previous Short Interest
26,040,000 shares
Change Vs. Previous Month
+0.73%
Dollar Volume Sold Short
$2.68 billion
Short Interest Ratio
2.8 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
2,529,640,000 shares
Percentage of Shares Shorted
1.04%
Today's Trading Volume
12,135,486 shares
Average Trading Volume
10,546,958 shares
Today's Volume Vs. Average
115%
Short Selling Merck & Co., Inc.?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Merck & Co., Inc. and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MRK Short Interest Over Time

MRK Days to Cover Over Time

MRK Percentage of Float Shorted Over Time

Merck & Co., Inc. Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202426,230,000 shares $2.68 billion +0.7%N/A2.8 $102.32
10/15/202426,040,000 shares $2.90 billion -4.5%N/A2.6 $111.54
9/30/202427,260,000 shares $3.10 billion +9.9%N/A2.9 $113.56
9/15/202424,810,000 shares $2.87 billion -4.3%N/A2.5 $115.86
8/31/202425,910,000 shares $3.07 billion +4.4%N/A2.7 $118.45
8/15/202424,810,000 shares $2.81 billion -7.2%N/A2.6 $113.31
7/31/202426,720,000 shares $3.02 billion +8.8%N/A2.9 $113.13
7/15/202424,570,000 shares $3.15 billion +5.2%N/A3 $128.12
6/30/202423,350,000 shares $2.89 billion +19.9%N/A2.8 $123.80
6/15/202419,470,000 shares $2.52 billion -4.6%N/A2.6 $129.48
5/31/202420,410,000 shares $2.56 billion +0.7%N/A2.5 $125.58
5/15/202420,270,000 shares $2.67 billion +8.1%N/A2.5 $131.74
4/30/202418,750,000 shares $2.42 billion -8.2%N/A2.3 $129.19
4/15/202420,430,000 shares $2.58 billion +4.3%N/A2.5 $126.19
3/31/202419,590,000 shares $2.58 billion -15.4%N/A2.3 $131.95
3/15/202423,160,000 shares $2.81 billion +39.5%N/A2.8 $121.53
2/29/202416,600,000 shares $2.11 billion -1.3%N/A2.1 $127.15
2/15/202416,820,000 shares $2.13 billion -1.2%N/A2 $126.54
1/31/202417,020,000 shares $2.06 billion -18.2%N/A2 $120.78
1/15/202420,810,000 shares $2.47 billion +16.5%N/A2.5 $118.63
12/31/202317,870,000 shares $1.95 billion +32.7%N/A2.2 $109.02
12/15/202313,470,000 shares $1.42 billion -19.3%N/A1.7 $105.64
11/30/202316,690,000 shares $1.71 billion -7.4%N/A2.3 $102.48
11/15/202318,020,000 shares $1.83 billion +9.8%N/A2.7 $101.35
10/31/202316,410,000 shares $1.68 billion +3.9%N/A2.5 $102.68
10/15/202315,790,000 shares $1.64 billion +6.5%N/A2.4 $104.01
9/30/202314,830,000 shares $1.53 billion +6.8%N/A2.2 $102.95
9/15/202313,880,000 shares $1.49 billion -5.2%N/A2 $107.47
8/31/202314,640,000 shares $1.60 billion +1.2%N/A2 $108.98
8/15/202314,460,000 shares $1.57 billion +2.3%N/A1.9 $108.66
7/31/202314,140,000 shares $1.51 billion -21.1%N/A1.9 $106.65
7/15/202317,920,000 shares $1.92 billion +6.3%N/A2.5 $107.34
6/30/202316,860,000 shares $1.94 billion +12.7%N/A2.4 $115.36
6/15/202314,960,000 shares $1.64 billion -4.4%N/A2.1 $109.40
5/31/202315,650,000 shares $1.73 billion -20.2%N/A2.1 $110.41
5/15/202319,620,000 shares $2.28 billion +2.7%N/A2.6 $116.37
4/30/202319,100,000 shares $2.21 billion -10.5%N/A2.5 $115.47
4/15/202321,340,000 shares $2.46 billion -3.3%N/A2.6 $115.31
3/31/202322,070,000 shares $2.35 billion +13.0%N/A2.6 $106.39
3/15/202319,540,000 shares $2.10 billion -4.9%N/A2.3 $107.63
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
2/28/202320,550,000 shares $2.18 billion +5.6%N/A2.4 $106.24
2/15/202319,470,000 shares $2.10 billion +13.5%N/A2.2 $107.68
1/31/202317,150,000 shares $1.84 billion +5.7%N/A1.9 $107.41
1/15/202316,220,000 shares $1.82 billion -5.8%N/A1.7 $112.25
12/30/202217,210,000 shares $1.91 billion -16.1%N/A1.8 $110.95
12/15/202220,510,000 shares $2.25 billion +4.5%N/A2.2 $109.63
11/30/202219,630,000 shares $2.16 billion +0.8%N/A2.1 $110.12
11/15/202219,470,000 shares $1.94 billion -4.4%N/A2.2 $99.60
10/31/202220,360,000 shares $2.06 billion +5.8%N/A2.4 $101.20
10/15/202219,240,000 shares $1.77 billion -5.7%N/A2.3 $92.18
9/30/202220,400,000 shares $1.76 billion +4.9%N/A2.5 $86.12
9/15/202219,450,000 shares $1.69 billion +0.8%N/A2.2 $86.75
8/31/202219,290,000 shares $1.65 billion -2.4%N/A2 $85.36
8/15/202219,760,000 shares $1.79 billion +17.7%N/A1.9 $90.60
7/31/202216,790,000 shares $1.50 billion -17.4%N/A1.5 $89.34
7/15/202220,330,000 shares $1.93 billion -0.7%N/A1.8 $94.96
6/30/202220,470,000 shares $1.87 billion +2.6%N/A1.7 $91.17
6/15/202219,950,000 shares $1.69 billion -14.6%N/A1.7 $84.63
5/31/202223,350,000 shares $2.15 billion +8.3%N/A2 $92.03
5/15/202221,570,000 shares $1.95 billion +27.0%N/A1.9 $90.41
4/30/202216,980,000 shares $1.51 billion -11.9%0.7%1.5 $88.69
4/15/202219,280,000 shares $1.68 billion +14.4%0.8%1.6 $86.91
3/31/202216,860,000 shares $1.38 billion +1.6%0.7%1.4 $82.05
3/15/202216,590,000 shares $1.30 billion -14.8%0.7%1.4 $78.64
2/28/202219,460,000 shares $1.49 billion +10.3%0.8%1.5 $76.58
2/15/202217,650,000 shares $1.37 billion -12.2%0.7%1.3 $77.81
1/31/202220,090,000 shares $1.64 billion -14.5%0.8%1.4 $81.48
1/15/202223,490,000 shares $1.91 billion +1.4%0.9%1.7 $81.38
12/31/202123,160,000 shares $1.77 billion +8.8%0.9%1.7 $76.64
12/15/202121,290,000 shares $1.60 billion +13.7%0.8%1.3 $75.29
11/30/202118,730,000 shares $1.40 billion -15.6%0.7%1.1 $74.91
11/15/202122,180,000 shares $1.86 billion +6.4%0.9%1.5 $83.69
10/29/202120,840,000 shares $1.83 billion -4.8%N/A1.4 $88.05
10/15/202121,880,000 shares $1.71 billion -3.0%N/A1.6 $78.33
9/30/202122,560,000 shares $1.69 billion -19.9%N/A1.7 $75.11
9/15/202128,180,000 shares $2.05 billion +2.8%N/A2.7 $72.81
8/31/202127,420,000 shares $2.09 billion +2.7%N/A2.7 $76.29
8/13/202126,690,000 shares $2.05 billion +15.2%N/A2.5 $76.72
7/30/202123,170,000 shares $1.78 billion +4.1%N/A2.1 $76.87
7/15/202122,250,000 shares $1.73 billion -7.0%N/A1.9 $77.90
6/30/202123,930,000 shares $1.86 billion +8.4%N/A2 $77.77
6/15/202122,070,000 shares $1.67 billion +17.2%N/A1.9 $75.70
5/28/202118,830,000 shares $1.43 billion -9.4%N/A1.5 $75.89
5/14/202120,790,000 shares $1.64 billion +1.6%0.8%1.7 $78.69
4/30/202120,470,000 shares $1.51 billion -2.6%0.8%1.6 $73.68
4/15/202121,020,000 shares $1.61 billion -11.5%0.8%1.8 $76.40
3/31/202123,740,000 shares $1.83 billion +30.9%0.9%2 $76.96
3/15/202118,140,000 shares $1.35 billion -11.0%0.7%1.5 $74.60
2/26/202120,380,000 shares $1.52 billion +10.3%0.8%2 $74.62
2/12/202118,470,000 shares $1.38 billion -0.6%0.7%1.9 $74.74
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
1/29/202118,580,000 shares $1.45 billion +1.9%0.7%2 $77.92
1/15/202118,230,000 shares $1.50 billion +14.2%0.7%2 $82.17
12/31/202015,970,000 shares $1.29 billion +17.5%0.6%1.8 $80.59
12/15/202013,590,000 shares $1.09 billion +0.7%0.5%1.6 $80.32
11/30/202013,500,000 shares $1.08 billion +0.3%N/A1.6 $79.86
11/15/202013,460,000 shares $1.09 billion -8.8%0.5%1.6 $81.09
10/30/202014,750,000 shares $1.12 billion +40.1%0.6%1.8 $75.89
10/15/202010,530,000 shares $847.77 million -4.1%0.4%1.3 $80.51
9/30/202010,980,000 shares $910.79 million +0.1%0.4%1.4 $82.95
9/15/202010,970,000 shares $923.78 million -9.4%0.4%1.4 $84.21
8/31/202012,110,000 shares $1.03 billion +2.6%0.5%1.4 $85.27
8/14/202011,800,000 shares $985.06 million -13.9%0.5%1.3 $83.48
7/31/202013,700,000 shares $1.10 billion -6.4%0.5%1.4 $80.24
7/15/202014,640,000 shares $1.16 billion -1.6%0.6%1.5 $79.44
6/30/202014,880,000 shares $1.15 billion +2.2%0.6%1.4 $77.33
6/15/202014,560,000 shares $1.08 billion -7.9%0.6%1.3 $74.02
5/29/202015,810,000 shares $1.28 billion -16.8%0.6%1.2 $80.72
5/15/202018,990,000 shares $1.52 billion +0.5%0.8%1.4 $79.78
4/30/202018,890,000 shares $1.50 billion -8.4%0.8%1.4 $79.34
4/15/202020,610,000 shares $1.69 billion +12.9%0.8%1.5 $82.07
3/31/202018,260,000 shares $1.49 billion +0.5%0.7%1.3 $81.43
3/13/202018,162,700 shares $1.50 billion -12.6%0.7%1.7 $82.49
2/28/202020,780,000 shares $1.38 billion -7.9%0.8%1.9 $66.40
2/14/202022,560,000 shares $1.85 billion -10.9%0.9%2.4 $82.02
1/31/202025,330,000 shares $2.02 billion +1.7%1.0%2.9 $79.94
1/15/202024,920,000 shares $2.12 billion -0.9%1.0%2.9 $85.25
12/31/201925,150,000 shares $2.16 billion +3.2%1.0%3.1 $85.98

MRK Short Interest - Frequently Asked Questions

What is Merck & Co., Inc.'s current short interest?

Short interest is the volume of Merck & Co., Inc. shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 26,230,000 shares of MRK short. Learn More on Merck & Co., Inc.'s current short interest.

What is a good short interest ratio for Merck & Co., Inc.?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRK shares currently have a short interest ratio of 3.0. Learn More on Merck & Co., Inc.'s short interest ratio.

Which institutional investors are shorting Merck & Co., Inc.?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Merck & Co., Inc.: CTC LLC, Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Parkman Healthcare Partners LLC, Maven Securities LTD, Centiva Capital LP, Berkley W R Corp, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Citigroup Inc., MAI Capital Management, Marathon Trading Investment Management LLC, Gladius Capital Management LP, Mirae Asset Securities USA Inc., Wolverine Asset Management LLC, XY Capital Ltd, SpiderRock Advisors LLC, Genus Capital Management Inc., IMC Chicago LLC, Heritage Wealth Management Inc. CA , Concourse Financial Group Securities Inc., Oak Hill Wealth Advisors LLC, and Maven Securities LTD. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Merck & Co., Inc.'s short interest increasing or decreasing?

Merck & Co., Inc. saw a increase in short interest in October. As of October 31st, there was short interest totaling 26,230,000 shares, an increase of 0.7% from the previous total of 26,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Merck & Co., Inc.'s short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Merck & Co., Inc.: Eli Lilly and Company (0.78%), Johnson & Johnson (0.75%), AbbVie Inc. (1.03%), Pfizer Inc. (1.09%), Bristol-Myers Squibb (1.15%), Zoetis Inc. (0.96%), Royalty Pharma plc (3.84%), Jazz Pharmaceuticals plc (6.15%), Corcept Therapeutics Incorporated (20.84%), Perrigo Company plc (3.64%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Merck & Co., Inc. stock?

Short selling MRK is an investing strategy that aims to generate trading profit from Merck & Co., Inc. as its price is falling. MRK shares are trading up $0.89 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Merck & Co., Inc.?

A short squeeze for Merck & Co., Inc. occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MRK, which in turn drives the price of the stock up even further.

How often is Merck & Co., Inc.'s short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRK, twice per month. The most recent reporting period available is October, 31 2024.




This page (NYSE:MRK) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners